查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1298859

體外大腸癌篩查測試市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

In-vitro Colorectal Cancer Screening Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2022年，全球體外結直腸癌篩查測試市場規模達到9.43億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到13.52億美元，在2023-2028年期間呈現5.8%的成長率（CAGR）。

體外結直腸癌篩查試驗是為檢測腺瘤、息肉和結直腸癌症狀而進行的診斷程序。大腸癌是指一種以大腸、結腸和直腸細胞異常生長為特徵的醫學症狀。糞便隱血（FOB）、側向流免疫、轉鐵蛋白檢測、甲基化基因、生物標記和guaiac FOB糞便檢測是一些通常進行的篩查測試。體外結直腸癌篩查測試涉及到使用鏡頭捕捉消化道的圖像，並將其傳輸到綁在病人腰部的記錄器。它們是微創性的，可以幫助及時發現癌症。因此，體外大腸癌篩查試驗在診所、醫院和診斷實驗室廣泛開展。

體外結直腸癌篩查測試的市場趨勢：

結直腸癌在群眾中的發病率越來越高，這是推動市場成長的關鍵因素之一。此外，人們對早期發現和及時治療癌症的好處的認知不斷提高，對市場的成長產生了積極的影響。各種技術進步，如癌症篩查測試中的基因測試的整合，正在為市場成長提供推動力。這些測試有助於早期檢測，制定治療計劃，防止癌細胞擴散，最大限度地減少相關疾病的風險。與此相應，越來越多的人傾向於採用微創（MI）診斷程序來檢測結直腸癌，這有利於市場的成長。其他因素，包括老年人口的增加，更容易受到這種疾病的影響，醫療保健行業的顯著改善，以及各種政府計劃的實施，強制癌症篩查測試，預計將推動市場的成長。

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球體外大腸癌篩查測試市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按產品分類的市場

  • 糞便隱血試驗
    • 市場趨勢
    • 關鍵部分
      • 瓜亞克FOB糞便測試
      • 免疫性糞便凝集試驗
      • 側面流免疫-FOB測試
      • 免疫性FOB ELISA測試
    • 市場預測
  • 生物標記測試
    • 市場趨勢
    • 關鍵領域
      • 腫瘤M2-PK糞便測試
      • 轉鐵蛋白檢測
    • 市場預測
  • CRC DNA篩查測試
    • 市場趨勢
    • 關鍵領域
      • 甲基化基因檢測
      • DNA小組測試
    • 市場預測

第7章：按成像類型分類的市場

  • 結腸鏡檢查
    • 市場趨勢
    • 市場預測
  • 直腸鏡檢查
    • 市場趨勢
    • 市場預測
  • CT掃描
    • 市場趨勢
    • 市場預測
  • 超音波
    • 市場趨勢
    • 市場預測
  • 核磁共振
    • 市場趨勢
    • 市場預測
  • PET掃描
    • 市場趨勢
    • 市場預測

第8章：按終端用戶分類的市場

  • 醫院
    • 市場趨勢
    • 市場預測
  • 診所
    • 市場趨勢
    • 市場預測
  • 診斷實驗室
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十一章：價值鏈分析

第十二章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十三章：價格分析

第十四章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Beckman Coulter Inc. (Danaher Corporation)
    • Eiken Chemical Co. Ltd.
    • Epigenomics AG
    • Exact Sciences Corporation
    • Hemosure Inc.
    • Immunostics Inc. (Boditech Med Inc.)
    • Medline Industries LP
    • Merck KGaA
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • R-Biopharm AG
    • Siemens AG
    • Sysmex Corporation
Product Code: SR112023A5383

The global in-vitro colorectal cancer screening tests market size reached US$ 943 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,352 Million by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

In-vitro colorectal cancer screening tests are diagnostic procedures performed to detect adenomas, polyps and symptoms of colorectal cancer. Colorectal cancer refers to a medical condition that is characterized by the abnormal growth of cells in the large intestine, colon and rectum. Fecal occult blood (FOB), lateral flow immuno, transferrin assays, methylated gene, biomarker and guaiac FOB stool test are some of the commonly performed screening tests. In-vitro colorectal cancer screening tests involve the use of cameras that capture images of the digestive tract and transfers them to the recorder tied to the waist of the patient. They are minimally invasive and can aid in timely detection of cancer. As a result, in-vitro colorectal cancer screening tests are widely performed across clinics, hospitals and diagnostics laboratories.

In-Vitro Colorectal Cancer Screening Tests Market Trends:

The increasing prevalence of colorectal cancer among the masses is one of the key factors driving the growth of the market. Moreover, rising awareness regarding the benefits of early detection and timely treatment of cancer is positively impacting the market growth. Various technological advancements, such as the integration of genetic testing in cancer screening tests, are providing a thrust to the market growth. These tests aid in early detection, developing treatment plans, preventing the spread of cancerous cells and minimizing the risks of developing associated disorders. In line with this, the increasing preference for minimally invasive (MI) diagnostic procedures to detect colorectal cancer is favoring the market growth. Other factors, including rising geriatric populations, which is more susceptible to such ailments and significant improvements in the healthcare industry, along with the implementation of various government initiatives mandating cancer screening tests, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global In-vitro colorectal cancer screening tests market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, imaging type and end user.

Breakup by Product:

Fecal Occult Blood Tests

Guaiac FOB Stool Test

Immuno-FOB Agglutination Test

Lateral Flow Immuno-FOB Test

Immuno-FOB ELISA Test

Biomarker Tests

Tumor M2-PK Stool Test

Transferrin Assays

CRC DNA Screening Tests

Methylated Gene Testing

Panel DNA Tests

Breakup by Imaging Type:

Colonoscopy

Proctoscopy

CT Scan

Ultrasound

MRI

PET Scan

Breakup by End User:

Hospitals

Clinics

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Beckman Coulter Inc. (Danaher Corporation), Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corporation, Hemosure Inc., Immunostics Inc. (Boditech Med Inc.), Medline Industries LP, Merck KGaA, Qiagen N.V., Quest Diagnostics Incorporated, R-Biopharm AG, Siemens AG and Sysmex Corporation.

Key Questions Answered in This Report

1. What was the size of the global in-vitro colorectal cancer screening tests market in 2022?

2. What is the expected growth rate of the global in-vitro colorectal cancer screening tests market during 2023-2028?

3. What has been the impact of COVID-19 on the global in-vitro colorectal cancer screening tests market?

4. What are the key factors driving the global in-vitro colorectal cancer screening tests market?

5. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the product?

6. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the imaging type?

7. What is the breakup of the global in-vitro colorectal cancer screening tests market based on end user?

8. What are the key regions in the global in-vitro colorectal cancer screening tests market?

9. Who are the key players/companies in the global in-vitro colorectal cancer screening tests market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global In-vitro Colorectal Cancer Screening Tests Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Product

  • 6.1  Fecal Occult Blood Tests
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Guaiac FOB Stool Test
      • 6.1.2.2 Immuno-FOB Agglutination Test
      • 6.1.2.3 Lateral Flow Immuno-FOB Test
      • 6.1.2.4 Immuno-FOB ELISA Test
    • 6.1.3 Market Forecast
  • 6.2  Biomarker Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Tumor M2-PK Stool Test
      • 6.2.2.2 Transferrin Assays
    • 6.2.3 Market Forecast
  • 6.3  CRC DNA Screening Tests
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Methylated Gene Testing
      • 6.3.2.2 Panel DNA Tests
    • 6.3.3 Market Forecast

7   Market Breakup by Imaging Type

  • 7.1  Colonoscopy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Proctoscopy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  CT Scan
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Ultrasound
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5  MRI
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6  PET Scan
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Diagnostic Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4  Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2  Eiken Chemical Co. Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3  Epigenomics AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  Exact Sciences Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5  Hemosure Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6  Immunostics Inc. (Boditech Med Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7  Medline Industries LP
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8  Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9  Qiagen N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10  Quest Diagnostics Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11  R-Biopharm AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12  Siemens AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13  Sysmex Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: In-vitro Colorectal Cancer Screening Tests Market: Major Drivers and Challenges
  • Figure 2: Global: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Product (in %), 2022
  • Figure 5: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Imaging Type (in %), 2022
  • Figure 6: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by End User (in %), 2022
  • Figure 7: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Region (in %), 2022
  • Figure 8: Global: In-vitro Colorectal Cancer Screening Tests (Fecal Occult Blood Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: In-vitro Colorectal Cancer Screening Tests (Fecal Occult Blood Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: In-vitro Colorectal Cancer Screening Tests (Biomarker Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: In-vitro Colorectal Cancer Screening Tests (Biomarker Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: In-vitro Colorectal Cancer Screening Tests (CRC DNA Screening Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: In-vitro Colorectal Cancer Screening Tests (CRC DNA Screening Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: In-vitro Colorectal Cancer Screening Tests (Colonoscopy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: In-vitro Colorectal Cancer Screening Tests (Colonoscopy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: In-vitro Colorectal Cancer Screening Tests (Proctoscopy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: In-vitro Colorectal Cancer Screening Tests (Proctoscopy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: In-vitro Colorectal Cancer Screening Tests (CT Scan) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: In-vitro Colorectal Cancer Screening Tests (CT Scan) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: In-vitro Colorectal Cancer Screening Tests (Ultrasound) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: In-vitro Colorectal Cancer Screening Tests (Ultrasound) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: In-vitro Colorectal Cancer Screening Tests (MRI) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: In-vitro Colorectal Cancer Screening Tests (MRI) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: In-vitro Colorectal Cancer Screening Tests (PET Scan) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: In-vitro Colorectal Cancer Screening Tests (PET Scan) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: In-vitro Colorectal Cancer Screening Tests (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: In-vitro Colorectal Cancer Screening Tests (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: In-vitro Colorectal Cancer Screening Tests (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: In-vitro Colorectal Cancer Screening Tests (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: In-vitro Colorectal Cancer Screening Tests (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: In-vitro Colorectal Cancer Screening Tests (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: In-vitro Colorectal Cancer Screening Tests (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: In-vitro Colorectal Cancer Screening Tests (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: North America: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: North America: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: United States: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: United States: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Canada: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Canada: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Asia-Pacific: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Asia-Pacific: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: China: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: China: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Japan: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Japan: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: India: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: India: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: South Korea: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: South Korea: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Australia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Australia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Indonesia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Indonesia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Europe: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Europe: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Germany: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Germany: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: France: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: France: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: United Kingdom: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: United Kingdom: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Italy: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Italy: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Spain: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Spain: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Russia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Russia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Latin America: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Latin America: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Brazil: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Brazil: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Mexico: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Mexico: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Country (in %), 2022
  • Figure 82: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Global: In-vitro Colorectal Cancer Screening Tests Industry: SWOT Analysis
  • Figure 84: Global: In-vitro Colorectal Cancer Screening Tests Industry: Value Chain Analysis
  • Figure 85: Global: In-vitro Colorectal Cancer Screening Tests Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In-vitro Colorectal Cancer Screening Tests Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Imaging Type (in Million US$), 2023-2028
  • Table 4: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: In-vitro Colorectal Cancer Screening Tests Market: Competitive Structure
  • Table 7: Global: In-vitro Colorectal Cancer Screening Tests Market: Key Players